{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T23:00:46Z","timestamp":1765666846899},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,7,10]],"date-time":"2009-07-10T00:00:00Z","timestamp":1247184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s00296-009-1056-7","type":"journal-article","created":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T04:32:41Z","timestamp":1247113961000},"page":"749-753","source":"Crossref","is-referenced-by-count":37,"title":["Adherence to treatment guidelines in two primary care populations with gout"],"prefix":"10.1007","volume":"30","author":[{"given":"Geoffrey C.","family":"Wall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carrie F.","family":"Koenigsfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karly A.","family":"Hegge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle M.","family":"Bottenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,7,10]]},"reference":[{"key":"1056_CR1","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMcp030733","volume":"349","author":"RA Terkeltaub","year":"2003","unstructured":"Terkeltaub RA (2003) Gout. N Engl J Med 349:1647\u20131655. doi: 10.1056\/NEJMcp030733","journal-title":"N Engl J Med"},{"key":"1056_CR2","first-page":"2403","volume":"29","author":"E Arromdee","year":"2002","unstructured":"Arromdee E, Michet CJ, Crowson CS, O\u2019Fallon WM, Gabriel SE (2002) Epidemiology of gout: is the incidence rising? J Rheumatol 29:2403\u20132406","journal-title":"J Rheumatol"},{"key":"1056_CR3","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/art.20102","volume":"50","author":"TR Mikuls","year":"2004","unstructured":"Mikuls TR, MacLean CH, Olivieri J, Patino F, Allison JJ, Farrar JT, Bilker WB, Saag KG (2004) Quality of care indicators for gout management. Arthritis Rheum 50:937\u2013943. doi: 10.1002\/art.20102","journal-title":"Arthritis Rheum"},{"key":"1056_CR4","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/ard.2006.055251","volume":"65","author":"W Zhang","year":"2006","unstructured":"Zhang W, Doherty M, Pascual E et al (2006) EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65:1301\u20131311. doi: 10.1136\/ard.2006.055251","journal-title":"Ann Rheum Dis"},{"key":"1056_CR5","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","volume":"65","author":"W Zhang","year":"2006","unstructured":"Zhang W, Doherty M, Bardin T et al (2006) EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65:1312\u20131324. doi: 10.1136\/ard.2006.055269","journal-title":"Ann Rheum Dis"},{"key":"1056_CR6","doi-asserted-by":"crossref","first-page":"925","DOI":"10.4065\/81.7.925","volume":"81","author":"CA Sarawate","year":"2006","unstructured":"Sarawate CA, Brewer KK, Yang W et al (2006) Gout medication treatment patterns and adherence to standards of care from a managed care perspective. Mayo Clin Proc 81:925\u2013934. doi: 10.4065\/81.7.925","journal-title":"Mayo Clin Proc"},{"key":"1056_CR7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s100670050005","volume":"19","author":"B Pal","year":"2000","unstructured":"Pal B, Foxall M, Dysart T, Carey F, Whittaker M (2000) How is gout managed in primary care? A review of current practice and proposed guidelines. Clin Rheumatol 19:21\u201325. doi: 10.1007\/s100670050005","journal-title":"Clin Rheumatol"},{"key":"1056_CR8","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/rheumatology\/keh679","volume":"44","author":"TR Mikuls","year":"2005","unstructured":"Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Saag KG (2005) Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD). Rheumatology (Oxford) 44:1038\u20131042. doi: 10.1093\/rheumatology\/keh679","journal-title":"Rheumatology (Oxford)"},{"key":"1056_CR9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/01.rhu.0000209882.50228.9f","volume":"12","author":"CA Sarawate","year":"2006","unstructured":"Sarawate CA, Patel PA, Schumacher HR et al (2006) Serum urate levels and gout flares: analysis from managed care data. J Clin Rheumatol 12:61\u201365. doi: 10.1097\/01.rhu.0000209882.50228.9f","journal-title":"J Clin Rheumatol"},{"key":"1056_CR10","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3899\/jrheum.080768","volume":"36","author":"JG Hanly","year":"2009","unstructured":"Hanly JG, Skedgel C, Sketris I et al (2009) Gout in the elderly\u2014a population health study. J Rheumatol 36:822\u2013830. doi: 10.3899\/jrheum.080768","journal-title":"J Rheumatol"},{"key":"1056_CR11","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0895-7061(03)00060-8","volume":"16","author":"D Siegel","year":"2003","unstructured":"Siegel D, Lopez J, Meier J, Goldstein MK, Lee S, Brazill BJ, Matalka MS (2003) Academic detailing to improve antihypertensive prescribing patterns. Am J Hypertens 16:508\u2013511. doi: 10.1016\/S0895-7061(03)00060-8","journal-title":"Am J Hypertens"},{"key":"1056_CR12","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1001\/archinte.167.6.586","volume":"167","author":"TC Bailey","year":"2007","unstructured":"Bailey TC, Noirot LA, Blickensderfer A, Rachmiel E, Schaiff R, Kessels A, Braverman A, Goldberg A, Waterman B, Dunagan WC (2007) An intervention to improve secondary prevention of coronary heart disease. Arch Intern Med 167:586\u2013590. doi: 10.1001\/archinte.167.6.586","journal-title":"Arch Intern Med"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-009-1056-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-009-1056-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-009-1056-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:16:18Z","timestamp":1559042178000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-009-1056-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,10]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["1056"],"URL":"https:\/\/doi.org\/10.1007\/s00296-009-1056-7","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,10]]}}}